Avecho Biotechnology Limited (ASX:AVE)

Australia · Delayed Price · Currency is AUD

0.0100

+0.0010 (11.11%)

At close: Mar 4, 2026

Revenue by Segment

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Production			473.55K	1.13M	786.10K	327.99K	4.20M
Production Growth			-58.07%	43.65%	139.68%	-92.20%	233.99%
Human Health			-	-	7.50K	56.64K	33.59K
Human Health Growth			-	-	-86.76%	68.63%	-75.19%
Total			473.55K	1.13M	793.60K	384.63K	4.24M
Total Growth			-58.07%	42.30%	106.33%	-90.92%	203.97%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Australia			38.31K	24.55K	96.30K	4.10K	26.30K
Australia Growth			56.04%	-74.51%	2248.76%	-84.41%	-27.95%
Switzerland			403.44K	1.01M	583.46K	323.89K	533.79K
Switzerland Growth			-60.05%	73.10%	80.14%	-39.32%	-49.20%
India			31.80K	25.50K	113.84K	56.64K	106.59K
India Growth			24.70%	-77.60%	100.99%	-46.86%	-8.13%
United States			-	69.26K	-	-	3.57M
United States Growth			-	-	-	-	4564.75%
Total			473.55K	1.13M	793.60K	384.63K	4.24M
Total Growth			-58.07%	42.30%	106.33%	-90.92%	203.97%

Source: S&P Global Market Intelligence.